Rega Institute for Medical Research (BE)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
162
Publications
3987
Citations
145402
i10-index
2114
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Therapeutic options for the 2019 novel coronavirus... | 2020 | 1815 |
Human tumour necrosis factor: precursor structure,... | 1984 | 1733 |
Rapid and automated tetrazolium-based colorimetric... | 1988 | 1646 |
Approved Antiviral Drugs over the Past 50 Years | 2016 | 1388 |
CXCR4-activated astrocyte glutamate release via TN... | 2001 | 1053 |
Antiviral drugs in current clinical use | 2004 | 939 |
Human transforming growth factor-α: Precursor stru... | 1984 | 884 |
A novel selective broad-spectrum anti-DNA virus ag... | 1986 | 762 |
AMD3100, a small molecule inhibitor of HIV-1 entry... | 1998 | 759 |
Potent and selective inhibition of HIV-1 replicati... | 1990 | 754 |
Erik De Clercq is a researcher with 3987 publications and 145402 citations. They are affiliated with Rega Institute for Medical Research. Their research focuses on . With an h-index of 162, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Erik De Clercq and 250M+ other papers.
Citations per publication by year